Form 8-K Roivant Sciences Ltd. For: Nov 10

Go back to Form 8-K Roivant Sciences Ltd. For: Nov 10

Roivant Sciences (ROIV) PT Raised to $26 at Citi

November 10, 2025 3:58 PM EST

Citi analyst Samantha Semenkow raised the price target on Roivant Sciences (NASDAQ: ROIV) to $26.00 (from $25.00) while maintaining a Buy rating.

Removes 90-Day Upside Catalyst Watch... More